SNMMI NEWS
- July 6, 2022 —
In the July Issue of The Journal of Nuclear Medicine
Editorial—Unacceptable denials of PSMA-Targeted PET/CT imaging … COVID-19 and the brain … Standard of care—Alzheimer disease … Radiotracers in cardiovascular imaging … Women authors in nuclear medicine journals … Featured: C-11-PiB PET in AL cardiac amyloidosis … Pretargeting and trastuzumab combination … and more. (Press Releases) - June 29, 2022 —
Journal of Nuclear Medicine Impact Factor Rises Again
The Journal of Nuclear Medicine has again achieved the highest impact factor in its history, ranking fourth among all medical imaging journals worldwide, according to new data just released in Clarivate's 2021 Journal Citation Reports. (Press Releases) - June 27, 2022 —
Aetna Reverses Cardiac PET/CT Non-Coverage & Updates Policy for PSMA Therapy
SNMMI and ASNC requested that Aetna reverse its non-coverage cardiac PET/CT policy. We are thrilled to communicate that within a few days of receiving our letter, Aetna reversed the policy. Also, Aetna recently updated and published their coverage policy for PSMA imaging for PLUVICTO therapy eligibility. (Government Relations News) - June 24, 2022 —
CMS Reopens NCD for Beta Amyloid PET in Dementia and Neurodegenerative Disease
On June 16, 2022, the Centers for Medicare and Medicaid Services (CMS) began a reconsideration process for its National Coverage Determination (NCD) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease (Government Relations News) - June 16, 2022 —
Nuclear Medicine and Molecular Imaging Community Gathers at SNMMI 2022 Annual Meeting
SNMMI hosted more than 6,700 physicians, technologists, pharmacists, laboratory professionals, scientists and others at its 2022 Annual Meeting last week in Vancouver, British Columbia, Canada. (Press Releases) - June 14, 2022 —
SNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling after Heart Attack
Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, Ga-68-FAPI-46. The detailed depiction of Ga-68-FAPI-46 PET signal after acute anterior myocardial infarction has been selected as SNMMI’s 2022 Image of the Year. (Press Releases) - June 14, 2022 —
SNNMI Abstract of the Year: Targeted Radionuclide Treatment Achieves High Response Rate, Minimal Toxicities for Advanced-Stage Neuroendocrine Tumors
A targeted radionuclide alpha therapy, Ac-225 DOTATATE, has been shown to have long-term anti-tumor effects in patients with advanced-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs). (Press Releases) - June 14, 2022 —
Novel Radiopharmaceutical Pair Detects and Treats Melanoma; Study Shows Potential for Broad Application in Solid Tumors
A newly developed small-molecular radiopharmaceutical pair has successfully visualized and treated melanoma in a preclinical study, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting. (Press Releases)
CONTINUING EDUCATION
New! ASNC/SNMMI 80 Hour Authorized User Training Course
The new online ASNC/SNMMI 80 Hour Authorized User Training Course is designed to provide nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their practice. Learn More »
New! SNMMI Qualified Systems Personnel Training Program (QSPTP)
The SNMMI Qualified Systems Personnel Training Program (QSPTP) has been developed to define the competencies of a Qualified Person in the release of manufactured radiopharmaceuticals, providing experts in the field of radiopharmaceutical science guidance in program development. Learn More »
SNMMI Webinars
Access upcoming and recorded webinars from the new SNMMI Webinars website. Learn More »
Nuclear Medicine Online Review Course
Covering the most essential topics in nuclear medicine—you'll build the level of expertise you need to ace your exam! AMA PRA Category 1 credits available. Learn More »
Radiation Safety+ Review and Essentials
The Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination. Learn More »
CT+ Review and Essentials
CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). Learn More »
Member Benefit! Complimentary Journal SAMs/Journal CE
Free Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more »
PUBLICATIONS
Journal of Nuclear Medicine
Journal of Nuclear Medicine Technology
Molecular Imaging
Journal
FEDERAL LEGISLATIVE EFFORTS
FEATURED VIDEO
UPCOMING EVENTS
-
Viva Las Vegas
July 9 – 10, 2022 | Las Vegas , United States | Pacific South West Technologist Section VIVA LAS VEGAS meeting. See Event Details ► -
Radionuclide Theranostics for the Management of Cancer
July 17 – 22, 2022 | Newry See Event Details ► -
RAD Conference
July 25 – 26, 2022 | Herceg Novi , Montenegro See Event Details ►
SOCIAL MEDIA
Featured Jobs from SNMMI's Career Center
EDUCATION AND RESEARCH FOUNDATION
ERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More »